Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial-Reference-Cited by-同舟云学术

Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial

Published:2019-11 Issue:11 Volume:7 Page:855-865
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Fleseriu Maria,Pivonello Rosario,Elenkova Atanaska,Salvatori Roberto,Auchus Richard J,Feelders Richard A,Geer Eliza B,Greenman Yona,Witek Przemyslaw,Cohen Fredric,Biller Beverly M K

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement;Biller;J Clin Endocrinol Metab,2008

2. Cushing's syndrome: an update on current pharmacotherapy and future directions;Creemers;Expert Opin Pharmacother,2015

3. Complications of Cushing's syndrome: state of the art;Pivonello;Lancet Diabetes Endocrinol,2016

4. Overall and disease-specific mortality in patients with Cushing's disease: a Swedish nationwide study;Ragnarsson;J Clin Endocrinol Metab,2019

5. The treatment of Cushing's disease;Pivonello;Endocr Rev,2015

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review;Indian Journal of Endocrinology and Metabolism;2024-07

2. Medical treatment of functional pituitary adenomas, trials and tribulations;Journal of Neuro-Oncology;2024-05-18

3. Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease;Journal of Endocrinological Investigation;2024-05-02

4. Medical Therapy of Endogenous Cushing’s Syndrome with Steroidogenesis Inhibitors: Treatment Rationale, Available Drugs, and Therapeutic Effects;Experimental and Clinical Endocrinology & Diabetes;2024-04-30

5. Steroidogenic cytochrome P450 enzymes as drug target;Toxicological Research;2024-04-22